Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ultraproct ointment
0107020F0BBAAAA
|
Ultraproct | Fluocortolone | Gastro-Intestinal System | 92 |
|
Ultraproct suppositories
0107020F0BBABAB
|
Ultraproct | Fluocortolone | Gastro-Intestinal System | 85 |
|
Fluocortolone 0.25% / Fluocortolone hexanoate 0.25% ointment
1304000R0AABBBB
|
Fluocortolone | Fluocortolone | Skin | No data available |
|
Fluocortolone hexan 0.25%/Fluocortolone pival 0.25% crm
1304000R0AAABAB
|
Fluocortolone | Fluocortolone | Skin | No data available |
|
Generic Ultraproct ointment
0107020F0AAAAAA
|
Generic ointment | Fluocortolone | Gastro-Intestinal System | No data available |
|
Generic Ultraproct suppositories
0107020F0AAABAB
|
Generic ointment | Fluocortolone | Gastro-Intestinal System | No data available |
|
Ultralanum Plain cream
1304000R0BDAAAB
|
Ultralanum | Fluocortolone | Skin | No data available |
|
Ultralanum Plain ointment
1304000R0BDABBB
|
Ultralanum | Fluocortolone | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.